Attendance

October 27–30 | Walter E. Washington Convention Center | Washington, D.C.

Exclusive Startup Discount

At CRF®, we recognize the financial hurdles startups often encounter. That’s why we’re thrilled to offer eligible startups an exclusive discount of up to 40% off registration fees.


Are You A Startup Company Interested In TCT®? Get More for Less!

Apply by Monday, October 21, 2024, at 11:59 PM (EDT, UTC -4).

Startup Discount Eligibility Criteria

Startup Companies must meet all the listed criteria to be eligible for the discount.

  • The startup company must have a single product under pre-clinical or clinical evaluation.
  • The company is not operating as a subsidiary of any other company.
  • Does not have any products with regulatory approvals including, but not limited to CE mark, FDA, or similar certifications.
  • The company must be privately funded (non-public).
  • The startup company is not generating revenues through any commercialization efforts.


Take Advantage of Multiple Discount Opportunities!

Important: Discount will be applied to the prevailing Full Access rates and registration type at the time of registration.

How It Works — Submit Your Inquiry

Take the first step towards exclusive discounts for your startup. Fill out our inquiry form. Please note only startup companies who meet all the qualifications are eligible for this offer.

If your submission meets the criteria, a member of our team will reach out to you within five business days with additional information. Submission of this form does not constitute registration for TCT® - Transcatheter Cardiovascular Therapeutics® 2024.

Apply by Monday, October 21, 2024, at 11:59 PM (EDT, UTC -4).

Join The Conversation #TCT2024

CRF Logo

Sign Up for Our Newsletter

Get the latest news and information from CRF.

By submitting your email address, you agree to CRF's Privacy Policy & Terms and Conditions.

1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
[email protected]

© 2024, Cardiovascular Research Foundation®. All rights reserved.

Privacy Policy
Terms and Conditions of Use

This website uses cookies to ensure you get the best experience on our website. Read More